Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Recognizing and overcoming potential barriers to oral medications for MS.
Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders.
A pilot study of an exercise-based patient education program in people with multiple sclerosis.
[The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
Longitudinal MR Imaging of Iron in Multiple Sclerosis: An Imaging Marker of Disease.
Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: A case report and literature review.
Lipid Resonance on In Vivo Proton MR Spectroscopy: Value of Other Metabolites in Differential Diagnosis.
Sexuality and multiple sclerosis.
Investigation of gene-gene interactions between CD40 and CD40L in Polish multiple sclerosis patients.
Diminished schwann cell repair responses underlie age-associated impaired axonal regeneration.
Increase in multiple sclerosis activity after assisted reproduction technology.
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.
Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.
Cucurbitacins attenuate microglial activation and protect from neuroinflammatory injury through Nrf2/ARE activation and STAT/NF-κB inhibition.
Serial electrophysiological studies in a Guillain-Barré subtype with bilateral facial neuropathy.
The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits.
Elevated CSF histamine levels in multiple sclerosis patients.
Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease.
Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis.
Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations.
Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis.
EBNA-1 IgG titers in Sardinian multiple sclerosis patients and controls.
Treatment of multiple sclerosis in Germany: an analysis based on claims data of more than 30,000 patients.

Pages